Kit for prevention or treatment of Alzheimer's disease comprises means (M1) for inducing sequestration of amyloid beta in plasma, and apheresis apparatus (A1), containing a solid carrier contactable with blood or plasma fluid, which exhibits an amyloid beta precursor protein (APP) receptor (I). Independent claims are also included for the following: (1) method for the prevention or treatment of Alzheimer's disease comprising administering (M1) and treating the patient with (A1) where APP is removed from the patient's blood by (A1)； and (2) use of an amyloid beta mimotope for inclusion in combination therapy comprising (M1) and (A1) for prevention or treatment of Alzheimer's disease. ACTIVITY : Neuroprotective: Nootropic. MECHANISM OF ACTION : None given.
